Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Vial sizes change
In this current network meta-analysis, we evaluated 23 CVOTs, including the most recently published trials AMPLITUDE-O and EMPEROR-P
Markey KA, Ottridge R, Mitchell JL et al (2017) Assessing the Efficacy and Safety of an 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial
Youll receive expert advice on diet, exercise, and continuous monitoring in a nurturing environment
US$ 25.15
US$ 26.65
US$ 28.83
US$ 26.86
